HERBALIFE LTD. Interest Expense
HERBALIFE LTD. (HLF) reported Interest Expense of $37.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-05
- HERBALIFE LTD. interest expense for the quarter ending 2026-06-30 was $37.40M, a 30.22% decline year-over-year.
- HERBALIFE LTD. interest expense for the quarter ending 2026-03-31 was $46.80M, a 10.00% decline year-over-year.
- HERBALIFE LTD. interest expense for the quarter ending 2025-12-31 was $57.80M, a 12.69% decline year-over-year.
- HERBALIFE LTD. interest expense for the quarter ending 2025-09-30 was $51.00M, a 9.73% decline year-over-year.
- HERBALIFE LTD. interest expense for fiscal 2025 was $214.40M, a 1.79% decline from fiscal 2024.
- HERBALIFE LTD. interest expense for fiscal 2024 was $218.30M, a 31.59% increase from fiscal 2023.
- HERBALIFE LTD. interest expense for fiscal 2023 was $165.90M, a 19.10% increase from fiscal 2022.
- HERBALIFE LTD. interest expense for fiscal 2022 was $139.30M, a 9.01% decline from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $37.40M 10-Q · filed 2026-08-05 | $84.20M 10-Q · filed 2026-08-05 | $142.00M derived: sum of 3 quarters · filed 2026-08-05 | $193.00M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $46.80M 10-Q · filed 2026-05-06 | $104.60M derived: sum of 2 quarters · filed 2026-05-06 | $155.60M derived: sum of 3 quarters · filed 2026-05-06 | $209.20M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $57.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $108.80M derived: sum of 2 quarters · filed 2026-02-18 | $162.40M derived: sum of 3 quarters · filed 2026-08-05 | $214.40M 10-K · filed 2026-02-18 | |
| 2025-09-30 | $51.00M 10-Q · filed 2025-11-05 | $104.60M derived: sum of 2 quarters · filed 2026-08-05 | $156.60M 10-Q · filed 2025-11-05 | $222.80M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $53.60M 10-Q · filed 2026-08-05 | $105.60M 10-Q · filed 2026-08-05 | $171.80M derived: sum of 3 quarters · filed 2026-08-05 | $228.30M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $52.00M 10-Q · filed 2026-05-06 | $118.20M derived: sum of 2 quarters · filed 2026-05-06 | $174.70M derived: sum of 3 quarters · filed 2026-05-06 | $232.40M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $66.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $122.70M derived: sum of 2 quarters · filed 2026-02-18 | $180.40M derived: sum of 3 quarters · filed 2026-02-18 | $218.30M 10-K · filed 2026-02-18 | |
| 2024-09-30 | $56.50M 10-Q · filed 2025-11-05 | $114.20M derived: sum of 2 quarters · filed 2025-11-05 | $152.10M 10-Q · filed 2025-11-05 | $201.70M derived: sum of 4 quarters · filed 2026-02-18 | |
| 2024-06-30 | $57.70M 10-Q · filed 2025-08-06 | $95.60M 10-Q · filed 2025-08-06 | $145.20M derived: sum of 3 quarters · filed 2026-02-18 | $183.70M derived: sum of 4 quarters · filed 2026-02-18 | |
| 2024-03-31 | $37.90M 10-Q · filed 2025-04-30 | $87.50M derived: sum of 2 quarters · filed 2026-02-18 | $126.00M derived: sum of 3 quarters · filed 2026-02-18 | $164.40M derived: sum of 4 quarters · filed 2026-02-18 | |
| 2023-12-31 | $49.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $88.10M derived: sum of 2 quarters · filed 2026-02-18 | $126.50M derived: sum of 3 quarters · filed 2026-02-18 | $165.90M 10-K · filed 2026-02-18 | |
| 2023-09-30 | $38.50M 10-Q · filed 2024-10-30 | $76.90M derived: sum of 2 quarters · filed 2024-10-30 | $116.30M 10-Q · filed 2024-10-30 | $159.70M derived: sum of 4 quarters · filed 2025-02-19 | |
| 2023-06-30 | $38.40M 10-Q · filed 2024-07-31 | $77.80M 10-Q · filed 2024-07-31 | $121.20M derived: sum of 3 quarters · filed 2025-02-19 | $155.70M derived: sum of 4 quarters · filed 2025-02-19 | |
| 2023-03-31 | $39.40M 10-Q · filed 2024-05-01 | $82.80M derived: sum of 2 quarters · filed 2025-02-19 | $117.30M derived: sum of 3 quarters · filed 2025-02-19 | $149.00M derived: sum of 4 quarters · filed 2025-02-19 | |
| 2022-12-31 | $43.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $77.90M derived: sum of 2 quarters · filed 2025-02-19 | $109.60M derived: sum of 3 quarters · filed 2025-02-19 | $139.30M 10-K · filed 2025-02-19 | |
| 2022-09-30 | $34.50M 10-Q · filed 2023-11-01 | $66.20M derived: sum of 2 quarters · filed 2023-11-01 | $95.90M 10-Q · filed 2023-11-01 | $137.00M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-06-30 | $31.70M 10-Q · filed 2023-08-02 | $61.40M 10-Q · filed 2023-08-02 | $102.50M derived: sum of 3 quarters · filed 2024-02-14 | $140.20M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-03-31 | $29.70M 10-Q · filed 2023-05-02 | $70.80M derived: sum of 2 quarters · filed 2024-02-14 | $108.50M derived: sum of 3 quarters · filed 2024-02-14 | $145.30M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2021-12-31 | $41.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $78.80M derived: sum of 2 quarters · filed 2024-02-14 | $115.60M derived: sum of 3 quarters · filed 2024-02-14 | $153.10M 10-K · filed 2024-02-14 | |
| 2021-09-30 | $37.70M 10-Q · filed 2022-10-31 | $74.50M derived: sum of 2 quarters · filed 2022-10-31 | $112.00M 10-Q · filed 2022-10-31 | $156.00M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-06-30 | $36.80M 10-Q · filed 2022-08-02 | $74.30M 10-Q · filed 2022-08-02 | $118.30M derived: sum of 3 quarters · filed 2023-02-14 | $153.50M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-03-31 | $37.50M 10-Q · filed 2022-05-03 | $81.50M derived: sum of 2 quarters · filed 2023-02-14 | $116.70M derived: sum of 3 quarters · filed 2023-02-14 | $145.50M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2020-12-31 | $44.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $79.20M derived: sum of 2 quarters · filed 2023-02-14 | $108.00M derived: sum of 3 quarters · filed 2023-02-14 | $133.00M 10-K · filed 2023-02-14 | |
| 2020-09-30 | $35.20M 10-Q · filed 2021-11-02 | $64.00M derived: sum of 2 quarters · filed 2021-11-02 | $89.00M 10-Q · filed 2021-11-02 | $138.00M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2020-06-30 | $28.80M 10-Q · filed 2021-08-03 | $53.80M 10-Q · filed 2021-08-03 | $102.80M derived: sum of 3 quarters · filed 2022-02-23 | $134.40M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2020-03-31 | $25.00M 10-Q · filed 2021-05-04 | $74.00M derived: sum of 2 quarters · filed 2022-02-23 | $105.60M derived: sum of 3 quarters · filed 2022-02-23 | $141.90M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2019-12-31 | $49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $80.60M derived: sum of 2 quarters · filed 2022-02-23 | $116.90M derived: sum of 3 quarters · filed 2022-02-23 | $153.00M 10-K · filed 2022-02-23 | |
| 2019-09-30 | $31.60M 10-Q · filed 2020-11-05 | $67.90M derived: sum of 2 quarters · filed 2020-11-05 | $104.00M 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $36.30M 10-Q · filed 2020-08-06 | $72.40M 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $36.10M 10-Q · filed 2020-05-07 | ||||
| 2018-12-31 | $181.00M 10-K · filed 2021-02-17 | ||||
| 2017-12-31 | $160.80M 10-K · filed 2020-02-18 | ||||
| 2016-12-31 | $99.30M 10-K · filed 2019-02-19 | ||||
| 2015-12-31 | $100.50M 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $1.30M 10-Q · filed 2015-11-03 | ||||
| 2014-12-31 | $91.70M 10-K · filed 2017-02-23 | ||||
| 2013-12-31 | $26.60M 10-K · filed 2016-02-25 | $26.55M 10-K · filed 2014-02-18 | |||
| 2012-12-31 | $16.74M 10-K · filed 2014-02-18 | ||||
| 2011-12-31 | $9.86M 10-K · filed 2014-02-18 | ||||
| 2010-12-31 | $9.66M 10-K/A · filed 2013-12-16 | ||||
| 2009-12-31 | $9.61M 10-K/A · filed 2012-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |